Hospitals saw revenues drop by over 50 percent last month after SARS clusters in several facilities kept all but the bravest people away from doctor appointments.
"In addition to over 50 percent revenue losses in May, National Taiwan University Hospital has spent over NT$100 million treating more than 200 SARS patients," hospital Vice Superintendent Hsu Su-ming (
Clinic visits at the facility plummeted after the outbreak of SARS in late April.
National Taiwan University Hospital -- the nation's leading hospital in treating SARS victims -- on average, saw only 2,000 to 3,000 patients a day last month -- down from 7,000 patients per day before the virus outbreak, Hsu said.
Its revenue losses are estimated to be in the hundred of millions of NT dollars after it took in the nation's first SARS patient in mid-March.
Hsu, however, said that after the nation began to contain SARS this month, the hospital began to see more people coming for treatment and now has about 4,000 appointments per day.
Although the government has promised to compensate hospitals for their losses stemming from treating SARS patients, National Taiwan University Hospital has been too busy to file a claim and so hasn't received any subsidies yet, Hsu said.
According to a local media report, large hospitals such as National Taiwan University Hospital, Veterans General Hospital and Mackay Memorial Hospital were hardest-hit by SARS, suffering revenue drops of at least 30 percent last month.
The report speculated that big hospitals might have incurred NT$6 billion in total losses last month, although it failed to provide details on the number of hospitals.
Officials at the Department of Health and the Bureau of National Health Insurance yesterday refused to confirm the report's accuracy, saying that figures will only be available after the SARS-affected hospitals complete their health insurance claims later this month.
Municipal hospitals, such as Taipei Municipal Jen Ai Hospital and Jen Chi Hospital, were also badly hit by the virus and suffered a 10 to 20 percent decline in business last month, according to the report.
After taking in 34 SARS patients, Chang Gung Memorial Hospital in Keelung saw a 30 percent decline in business last month, losing over NT$40 million in one month according to administrative supervisor Tai Hsin-yeh (
Early this month, however, the hospital's business began to recover, seeing only a 15 percent decline, Tai said.
To weather the SARS impact, he said that the hospital has encouraged its medical staff to take vacations or combine their practices.
The epidemic has also affected small clinics which have not been treating SARS cases.
The University Eye Center, which specializes in corrective laser eye surgery, saw business decline by 20 to 30 percent according to its marketing manager, Chen Jung-jay (陳榮杰).
Chen said that the center had treated many patients who suffered from eye disorders and required immediate care, but those seeking corrective surgery have been taking a wait-and-see approach before scheduling appointments.
SEASONAL WEAKNESS: The combined revenue of the top 10 foundries fell 5.4%, but rush orders and China’s subsidies partially offset slowing demand Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) further solidified its dominance in the global wafer foundry business in the first quarter of this year, remaining far ahead of its closest rival, Samsung Electronics Co, TrendForce Corp (集邦科技) said yesterday. TSMC posted US$25.52 billion in sales in the January-to-March period, down 5 percent from the previous quarter, but its market share rose from 67.1 percent the previous quarter to 67.6 percent, TrendForce said in a report. While smartphone-related wafer shipments declined in the first quarter due to seasonal factors, solid demand for artificial intelligence (AI) and high-performance computing (HPC) devices and urgent TV-related orders
BYPASSING CHINA TARIFFS: In the first five months of this year, Foxconn sent US$4.4bn of iPhones to the US from India, compared with US$3.7bn in the whole of last year Nearly all the iPhones exported by Foxconn Technology Group (富士康科技集團) from India went to the US between March and last month, customs data showed, far above last year’s average of 50 percent and a clear sign of Apple Inc’s efforts to bypass high US tariffs imposed on China. The numbers, being reported by Reuters for the first time, show that Apple has realigned its India exports to almost exclusively serve the US market, when previously the devices were more widely distributed to nations including the Netherlands and the Czech Republic. During March to last month, Foxconn, known as Hon Hai Precision Industry
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and the University of Tokyo (UTokyo) yesterday announced the launch of the TSMC-UTokyo Lab to promote advanced semiconductor research, education and talent development. The lab is TSMC’s first laboratory collaboration with a university outside Taiwan, the company said in a statement. The lab would leverage “the extensive knowledge, experience, and creativity” of both institutions, the company said. It is located in the Asano Section of UTokyo’s Hongo, Tokyo, campus and would be managed by UTokyo faculty, guided by directors from UTokyo and TSMC, the company said. TSMC began working with UTokyo in 2019, resulting in 21 research projects,
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) yesterday expressed a downbeat view about the prospects of humanoid robots, given high manufacturing costs and a lack of target customers. Despite rising demand and high expectations for humanoid robots, high research-and-development costs and uncertain profitability remain major concerns, Lam told reporters following the company’s annual shareholders’ meeting in Taoyuan. “Since it seems a bit unworthy to use such high-cost robots to do household chores, I believe robots designed for specific purposes would be more valuable and present a better business opportunity,” Lam said Instead of investing in humanoid robots, Quanta has opted to invest
RSS